The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1 single-dose study of TRX-518, an anti-human glucocorticoid-induced tumor necrosis factor receptor (GITR) monoclonal antibody in adults with advanced solid tumors.
 
Henry Koon
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Dale Randall Shepard
Honoraria - Celgene
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Celgene; Genentech/Roche; Novartis
Research Funding - Astellas Pharma; AstraZeneca; BioMed Valley Discoveries; GITR; Kinex; Millennium; Pfizer; Taiho Pharmaceutical
 
Taha Merghoub
Research Funding - Bristol-Myers Squibb; GITR (Inst); Infinity Pharmaceuticals; Merck (Inst); Peregrine Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Agenus (Inst)
 
David A. Schaer
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center
 
Cynthia A. Sirard
Employment - Leap Therapeutics
Stock and Other Ownership Interests - Leap Therapeutics
Patents, Royalties, Other Intellectual Property - Leap Therapeutics
 
Jedd D. Wolchok
Stock and Other Ownership Interests - Potenza Therapeutics; Vesuvius Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Jounce Therapeutics; MedImmune; Merck; Polaris; Polynoma; ZIOPHARM Oncology
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on an issued patent for DNA vaccines for treatment of cancer in companion animals.
Travel, Accommodations, Expenses - Bristol-Myers Squibb